Bovine spongiform encephalopathy: An overview

ASAIO Journal

Volumn 46, Issue 6, 2000, Pages

  Detwiler, Linda A ^a   Rubenstein, Richard ^b  

^a UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; DISEASES; ELECTRON MICROSCOPY; NEUROLOGY; PATHOLOGY; TISSUE;

BOVINE SPONGIFORM ENCEPHALOPATHY; CATTLE; LIVESTOCK INDUSTRY;

BIOMEDICAL ENGINEERING;

PRION PROTEIN; PROTEINASE;

AGRICULTURE; BOVINE SPONGIFORM ENCEPHALOPATHY; CATTLE; CREUTZFELDT JAKOB DISEASE; EPIDEMIC; EPIZOOTIOLOGY; FATAL FAMILIAL INSOMNIA; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HISTOPATHOLOGY; NONHUMAN; REVIEW; UNITED KINGDOM;

EID: 0034326871     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-200011000-00041     Document Type: Review

References (68)

1. Scrapie infectious agent is virus-like in size and susceptibility to inactivation
2. Virus like sensitivity of the scrapie agent to heat inactivation
3. Replication of scrapie agent in hamsters infected intracerebrally confirms the pathogenesis of an amyloid-inducing virosis
4. Potential involvement of retroviral elements in human dementias
5. Novel proteinaceous infectious particles cause scrapie
6. A modified host protein model of scrapie
7. The scrapie replication-site hypothesis and its implication for pathogenesis
8. Scrapie agent: Prions or virinos?
9. Search for specific DNAs in Creutzfeidt-Jakob infectious brain fractions using Anick translation
10. Isolation of cDNAs of scrapie-modulated RNAs by subtractive hybridization of a cDNA library
11. Search for a scrapie-specific nucleic acid: A progress report
12. Search for a putative scrapie genome in purified prion fractions reveals a paucity of nucleic acids
13. Nucleic acid binding proteins in highly purified Creutzfeldt-Jakob disease preparations
14. Resistance of the scrapie agent to inactivation by psoralens
15. Purified scrapie prions resist inactivation by UV irradiation
16. Purified scrapie prions resist inactivation by procedures that hydrolyze, modify, or shear nucleic acids
17. Protease sensitivity and nuclease resistance of the scrapie agent propagated in vitro in neuroblastoma cells
18. Virus-like particles in brain tissue from two patients with Creutzfeidt-Jakob disease
19. Isolation of 14-nm virus-like particles from mouse brain infected with scrapie agent
20. An extraordinarily small, suspicious, virus-like structure in fractions from scrapie hamster brain
21. Transgenic studies implicate interactions between homologous PrP isoforms in scrapie prion replication
22. Chimeric prion protein expression in cultured cells and transgenic mice
23. Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells
24. Cell free formation of protease-resistant prion protein
25. Non-genetic propagation of strain-specific properties of scrapie prion protein
26. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: A model for the scrapie species barrier
27. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms
28. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans
29. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state
30. Molecular biology of prion disease
31. A unified theory of priori propagation
32. Propagation of prion strains through specific conformers of the prion protein
33. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein
34. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein
35. A single amino acid alteration (101 L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy
36. Transmissible and genetic prion diseases share a common pathway of neurodegeneration
37. Bovine spongiform encephalopathy: Epidemiological features 1985 to 1990
38. Solvent extraction as an adjunct to rendering: The effect on BSE and scrapie agents of hot solvents followed by dry heat and steam
39. A cohort study to examine maternally associated risk factors for bovine spongiform encephalopathy
40. Transmission of bovine spongiform encephalopathy to sheep and goats
41. Experimental infection of mink with bovine spongiform encephalopathy
42. Primary parenteral transmission of bovine spongiform encephalopathy to the pig
43. Experimental transmission of BSE and scrapie to the common marmoset
44. BSE transmission to macaques
45. Transmission of bovine spongiform encephalopathy to mice
46. Dietary transmission of bovine spongiform encephalopathy to mice
47. A new variant of Creutzfeldt-Jakob disease in the UK
48. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent
49. The same prion strain causes vCJD and BSE
50. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD
51. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans
52. Failure to transmit bovine spongiform encephalopathy to mice by feeding them with extraneural tissues of affected cattle
53. Pathogenesis of the oral route of infection of mice with scrapie and bovine spongiform encephalopathy agents
54. Infectivity in the ileum of cattle challenged orally with bovine spongiform encephalopathy
55. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): An update
56. A novel progressive spongiform encephalopathy in cattle
57. Sulfated glycosaminoglycans in amyloid plaques of prion diseases
58. Congo red inhibition of scrapie agent replication
59. Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and Congo red
60. Effectiveness of anthracycline against experimental prion disease in Syrian hamsters
61. Specific inhibition of in vitro formation of protease resistant prion protein by synthetic peptides
62. Elimination of prions by branched polyamines and implications for therapeutics
63. Pathogenesis of mouse scrapie: Dynamics of agent replication in spleen, spinal cord, and brain after infection by different routes
64. PrP protein is associated with follicular dendritic cells of spleens and lymph nodes in uninfected and scrapie-infected mice
65. T-lymphocyte activation and the cellular form of the prion protein
66. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells
67. Detection of BSE infectivity in brain and spleen of experimentally infected sheep